Inflammatory response time course, HUVEC (Wada, 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RUNX1
|
ENSG00000159216.19 | RUNX1 |
RUNX2
|
ENSG00000124813.23 | RUNX2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RUNX2 | hg38_v1_chr6_+_45328203_45328372 | 0.64 | 5.7e-04 | Click! |
RUNX1 | hg38_v1_chr21_-_34888683_34888714 | 0.62 | 9.1e-04 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_132073782 | 5.95 |
ENST00000296871.4
|
CSF2
|
colony stimulating factor 2 |
chr1_-_173205543 | 3.58 |
ENST00000367718.5
|
TNFSF4
|
TNF superfamily member 4 |
chr6_-_11382247 | 2.07 |
ENST00000397378.7
ENST00000513989.5 ENST00000508546.5 ENST00000504387.5 |
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9 |
chr21_-_35049238 | 1.96 |
ENST00000416754.1
ENST00000437180.5 ENST00000455571.5 ENST00000675419.1 |
RUNX1
|
RUNX family transcription factor 1 |
chr21_-_35049327 | 1.89 |
ENST00000300305.7
|
RUNX1
|
RUNX family transcription factor 1 |
chr11_-_128587551 | 1.70 |
ENST00000392668.8
|
ETS1
|
ETS proto-oncogene 1, transcription factor |
chr20_-_63568074 | 1.62 |
ENST00000427522.6
|
HELZ2
|
helicase with zinc finger 2 |
chr5_+_35856883 | 1.58 |
ENST00000506850.5
ENST00000303115.8 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr17_+_34255274 | 1.50 |
ENST00000580907.5
ENST00000225831.4 |
CCL2
|
C-C motif chemokine ligand 2 |
chr2_+_102418642 | 1.49 |
ENST00000264260.6
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chr14_-_91253925 | 1.48 |
ENST00000531499.2
|
GPR68
|
G protein-coupled receptor 68 |
chr12_+_14973020 | 1.47 |
ENST00000266395.3
|
PDE6H
|
phosphodiesterase 6H |
chr5_+_126360113 | 1.39 |
ENST00000513040.5
|
GRAMD2B
|
GRAM domain containing 2B |
chr1_+_206470463 | 1.35 |
ENST00000581977.7
ENST00000578328.6 ENST00000584998.5 ENST00000579827.6 |
IKBKE
|
inhibitor of nuclear factor kappa B kinase subunit epsilon |
chr8_+_103371490 | 1.34 |
ENST00000330295.10
ENST00000415886.2 |
CTHRC1
|
collagen triple helix repeat containing 1 |
chr5_-_139482285 | 1.29 |
ENST00000652110.1
|
STING1
|
stimulator of interferon response cGAMP interactor 1 |
chr5_-_139482173 | 1.27 |
ENST00000652271.1
|
STING1
|
stimulator of interferon response cGAMP interactor 1 |
chr3_-_127722562 | 1.24 |
ENST00000487473.5
ENST00000484451.1 |
MGLL
|
monoglyceride lipase |
chr11_-_5324297 | 1.24 |
ENST00000624187.1
|
OR51B2
|
olfactory receptor family 51 subfamily B member 2 |
chr3_-_190122317 | 1.22 |
ENST00000427335.6
|
P3H2
|
prolyl 3-hydroxylase 2 |
chr5_-_139482341 | 1.20 |
ENST00000651699.1
|
STING1
|
stimulator of interferon response cGAMP interactor 1 |
chr8_-_118951876 | 1.20 |
ENST00000297350.9
|
TNFRSF11B
|
TNF receptor superfamily member 11b |
chr3_+_122680802 | 1.19 |
ENST00000474629.7
|
PARP14
|
poly(ADP-ribose) polymerase family member 14 |
chr10_+_89332484 | 1.18 |
ENST00000371811.4
ENST00000680037.1 ENST00000679583.1 ENST00000679897.1 |
IFIT3
|
interferon induced protein with tetratricopeptide repeats 3 |
chr9_+_113150991 | 1.09 |
ENST00000259392.8
|
SLC31A2
|
solute carrier family 31 member 2 |
chr16_+_85908988 | 1.07 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr2_+_126656128 | 1.07 |
ENST00000259254.9
ENST00000409836.3 ENST00000356887.12 |
GYPC
|
glycophorin C (Gerbich blood group) |
chr19_-_49155130 | 1.04 |
ENST00000595625.1
|
HRC
|
histidine rich calcium binding protein |
chr12_+_121132869 | 1.02 |
ENST00000328963.10
|
P2RX7
|
purinergic receptor P2X 7 |
chr10_+_89392546 | 0.98 |
ENST00000546318.2
ENST00000371804.4 |
IFIT1
|
interferon induced protein with tetratricopeptide repeats 1 |
chr6_-_137219028 | 0.98 |
ENST00000647124.1
ENST00000642390.1 ENST00000645753.1 ENST00000646036.1 ENST00000646898.1 ENST00000644894.1 |
IFNGR1
|
interferon gamma receptor 1 |
chr11_+_35176696 | 0.98 |
ENST00000528455.5
|
CD44
|
CD44 molecule (Indian blood group) |
chr11_+_35176575 | 0.96 |
ENST00000526000.6
|
CD44
|
CD44 molecule (Indian blood group) |
chr11_+_35176611 | 0.96 |
ENST00000279452.10
|
CD44
|
CD44 molecule (Indian blood group) |
chr2_-_224982420 | 0.94 |
ENST00000645028.1
|
DOCK10
|
dedicator of cytokinesis 10 |
chr13_+_49496355 | 0.94 |
ENST00000496612.5
ENST00000357596.7 ENST00000485919.5 ENST00000442195.5 |
PHF11
|
PHD finger protein 11 |
chr13_-_42992165 | 0.92 |
ENST00000398762.7
ENST00000313640.11 ENST00000313624.12 |
EPSTI1
|
epithelial stromal interaction 1 |
chr11_+_35176639 | 0.91 |
ENST00000527889.6
|
CD44
|
CD44 molecule (Indian blood group) |
chr3_-_128052166 | 0.89 |
ENST00000648300.1
|
MGLL
|
monoglyceride lipase |
chr17_+_76376581 | 0.89 |
ENST00000591651.5
ENST00000545180.5 |
SPHK1
|
sphingosine kinase 1 |
chr8_-_133060347 | 0.87 |
ENST00000427060.6
|
SLA
|
Src like adaptor |
chr17_-_63699730 | 0.87 |
ENST00000578061.5
|
LIMD2
|
LIM domain containing 2 |
chr17_-_20467535 | 0.86 |
ENST00000324290.5
ENST00000423676.8 |
LGALS9B
|
galectin 9B |
chr8_+_103372388 | 0.85 |
ENST00000520337.1
|
CTHRC1
|
collagen triple helix repeat containing 1 |
chr22_-_41285868 | 0.85 |
ENST00000422838.1
ENST00000405486.5 |
RANGAP1
|
Ran GTPase activating protein 1 |
chr1_-_32870775 | 0.85 |
ENST00000649537.2
ENST00000373471.9 |
FNDC5
|
fibronectin type III domain containing 5 |
chr9_+_100427123 | 0.83 |
ENST00000395067.7
|
MSANTD3
|
Myb/SANT DNA binding domain containing 3 |
chr6_+_29100609 | 0.80 |
ENST00000377171.3
|
OR2J1
|
olfactory receptor family 2 subfamily J member 1 |
chr6_+_31575557 | 0.79 |
ENST00000449264.3
|
TNF
|
tumor necrosis factor |
chr15_+_67125707 | 0.79 |
ENST00000540846.6
|
SMAD3
|
SMAD family member 3 |
chr9_+_100427254 | 0.79 |
ENST00000374885.5
|
MSANTD3
|
Myb/SANT DNA binding domain containing 3 |
chr1_+_205256189 | 0.78 |
ENST00000329800.7
|
TMCC2
|
transmembrane and coiled-coil domain family 2 |
chr6_+_31586680 | 0.77 |
ENST00000339530.8
|
LST1
|
leukocyte specific transcript 1 |
chr6_+_45328203 | 0.77 |
ENST00000371432.7
ENST00000647337.2 ENST00000371438.5 |
RUNX2
|
RUNX family transcription factor 2 |
chr2_+_201132769 | 0.77 |
ENST00000494258.5
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
chr14_+_22281097 | 0.77 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
chr11_+_94128834 | 0.76 |
ENST00000227638.8
ENST00000436171.2 |
PANX1
|
pannexin 1 |
chr22_+_24607638 | 0.76 |
ENST00000432867.5
|
GGT1
|
gamma-glutamyltransferase 1 |
chr6_-_137219340 | 0.74 |
ENST00000367739.9
ENST00000458076.5 ENST00000414770.5 |
IFNGR1
|
interferon gamma receptor 1 |
chr2_-_162318129 | 0.73 |
ENST00000679938.1
|
IFIH1
|
interferon induced with helicase C domain 1 |
chr4_-_7434895 | 0.73 |
ENST00000319098.7
|
PSAPL1
|
prosaposin like 1 |
chr11_-_72674394 | 0.72 |
ENST00000418754.6
ENST00000334456.10 ENST00000542969.2 |
PDE2A
|
phosphodiesterase 2A |
chr16_-_28610032 | 0.72 |
ENST00000567512.1
|
SULT1A1
|
sulfotransferase family 1A member 1 |
chr3_-_151203201 | 0.71 |
ENST00000480322.1
ENST00000309180.6 |
GPR171
|
G protein-coupled receptor 171 |
chr17_-_1187294 | 0.71 |
ENST00000544583.6
|
ABR
|
ABR activator of RhoGEF and GTPase |
chr3_+_50246888 | 0.69 |
ENST00000451956.1
|
GNAI2
|
G protein subunit alpha i2 |
chr10_+_102395693 | 0.67 |
ENST00000652277.1
ENST00000189444.11 ENST00000661543.1 |
NFKB2
|
nuclear factor kappa B subunit 2 |
chr3_+_190615308 | 0.67 |
ENST00000412080.1
|
IL1RAP
|
interleukin 1 receptor accessory protein |
chr5_-_35938572 | 0.67 |
ENST00000651391.1
ENST00000397366.5 ENST00000513623.5 ENST00000514524.2 ENST00000397367.6 |
CAPSL
|
calcyphosine like |
chr11_+_102317450 | 0.66 |
ENST00000615299.4
ENST00000527309.2 ENST00000526421.6 ENST00000263464.9 |
BIRC3
|
baculoviral IAP repeat containing 3 |
chr8_-_139654330 | 0.66 |
ENST00000647605.1
|
KCNK9
|
potassium two pore domain channel subfamily K member 9 |
chr2_+_102337148 | 0.66 |
ENST00000311734.6
ENST00000409584.5 |
IL1RL1
|
interleukin 1 receptor like 1 |
chr1_-_209651291 | 0.65 |
ENST00000391911.5
ENST00000415782.1 |
LAMB3
|
laminin subunit beta 3 |
chr12_-_49069970 | 0.64 |
ENST00000301068.11
|
RHEBL1
|
RHEB like 1 |
chr6_+_14117764 | 0.64 |
ENST00000379153.4
|
CD83
|
CD83 molecule |
chr11_-_72794032 | 0.63 |
ENST00000334805.11
|
STARD10
|
StAR related lipid transfer domain containing 10 |
chr6_+_36676455 | 0.63 |
ENST00000615513.4
|
CDKN1A
|
cyclin dependent kinase inhibitor 1A |
chr12_+_112906777 | 0.62 |
ENST00000452357.7
ENST00000445409.7 |
OAS1
|
2'-5'-oligoadenylate synthetase 1 |
chr6_+_36676489 | 0.62 |
ENST00000448526.6
|
CDKN1A
|
cyclin dependent kinase inhibitor 1A |
chr6_-_37257622 | 0.62 |
ENST00000650812.1
ENST00000497775.1 ENST00000478262.2 ENST00000356757.7 |
ENSG00000286105.1
TMEM217
|
novel transmembrane protein transmembrane protein 217 |
chr20_-_31723902 | 0.62 |
ENST00000676942.1
ENST00000450273.2 ENST00000678563.1 ENST00000456404.6 ENST00000420488.6 ENST00000439267.2 |
BCL2L1
|
BCL2 like 1 |
chr1_-_173207322 | 0.62 |
ENST00000281834.4
|
TNFSF4
|
TNF superfamily member 4 |
chr14_+_21918161 | 0.61 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
chr6_+_26440472 | 0.61 |
ENST00000494393.5
ENST00000482451.5 ENST00000471353.5 ENST00000361232.7 ENST00000487627.5 ENST00000496719.1 ENST00000244519.7 ENST00000490254.5 ENST00000487272.1 |
BTN3A3
|
butyrophilin subfamily 3 member A3 |
chr10_+_102394488 | 0.61 |
ENST00000369966.8
|
NFKB2
|
nuclear factor kappa B subunit 2 |
chr19_+_41262656 | 0.60 |
ENST00000599719.5
ENST00000601309.5 |
HNRNPUL1
|
heterogeneous nuclear ribonucleoprotein U like 1 |
chr17_+_18476737 | 0.60 |
ENST00000581545.5
ENST00000582333.5 ENST00000328114.11 ENST00000583322.5 ENST00000584941.5 |
LGALS9C
|
galectin 9C |
chr14_-_54902807 | 0.60 |
ENST00000543643.6
ENST00000536224.2 ENST00000395514.5 ENST00000491895.7 |
GCH1
|
GTP cyclohydrolase 1 |
chr19_-_49155384 | 0.59 |
ENST00000252825.9
|
HRC
|
histidine rich calcium binding protein |
chr6_-_37257643 | 0.59 |
ENST00000651039.1
ENST00000652495.1 ENST00000652218.1 |
TMEM217
|
transmembrane protein 217 |
chr3_-_99850976 | 0.58 |
ENST00000487087.5
|
FILIP1L
|
filamin A interacting protein 1 like |
chrX_+_68829009 | 0.58 |
ENST00000204961.5
|
EFNB1
|
ephrin B1 |
chr6_-_37257590 | 0.58 |
ENST00000336655.7
|
TMEM217
|
transmembrane protein 217 |
chr19_-_47471886 | 0.58 |
ENST00000236877.11
ENST00000597014.1 |
SLC8A2
|
solute carrier family 8 member A2 |
chrX_+_9463272 | 0.58 |
ENST00000407597.7
ENST00000380961.5 ENST00000424279.6 |
TBL1X
|
transducin beta like 1 X-linked |
chr19_-_2151525 | 0.58 |
ENST00000345016.9
ENST00000643116.3 |
AP3D1
|
adaptor related protein complex 3 subunit delta 1 |
chr1_+_172659095 | 0.57 |
ENST00000367721.3
ENST00000340030.4 |
FASLG
|
Fas ligand |
chr6_+_36678699 | 0.57 |
ENST00000405375.5
ENST00000244741.10 ENST00000373711.3 |
CDKN1A
|
cyclin dependent kinase inhibitor 1A |
chr2_-_228181669 | 0.57 |
ENST00000392056.8
|
SPHKAP
|
SPHK1 interactor, AKAP domain containing |
chr21_-_36542600 | 0.56 |
ENST00000399136.5
|
CLDN14
|
claudin 14 |
chr20_+_33079640 | 0.56 |
ENST00000375483.4
|
BPIFB4
|
BPI fold containing family B member 4 |
chr3_-_187736493 | 0.56 |
ENST00000232014.8
|
BCL6
|
BCL6 transcription repressor |
chrY_-_2500895 | 0.55 |
ENST00000461691.6_PAR_Y
ENST00000381222.8_PAR_Y ENST00000381223.9_PAR_Y ENST00000652001.1_PAR_Y ENST00000412516.7_PAR_Y ENST00000334651.11_PAR_Y |
ZBED1
DHRSX
|
zinc finger BED-type containing 1 dehydrogenase/reductase X-linked |
chr1_-_247758680 | 0.55 |
ENST00000408896.4
|
OR1C1
|
olfactory receptor family 1 subfamily C member 1 |
chr14_-_91244508 | 0.55 |
ENST00000535815.5
ENST00000529102.1 |
GPR68
|
G protein-coupled receptor 68 |
chrX_-_2500895 | 0.55 |
ENST00000461691.6
ENST00000381222.8 ENST00000381223.9 ENST00000652001.1 ENST00000412516.7 ENST00000334651.11 |
ZBED1
DHRSX
|
zinc finger BED-type containing 1 dehydrogenase/reductase X-linked |
chr16_+_84768246 | 0.55 |
ENST00000569925.1
ENST00000567526.1 |
USP10
|
ubiquitin specific peptidase 10 |
chr22_-_45240859 | 0.54 |
ENST00000336156.10
|
KIAA0930
|
KIAA0930 |
chr1_-_223363337 | 0.54 |
ENST00000608996.5
|
SUSD4
|
sushi domain containing 4 |
chr1_+_172452885 | 0.54 |
ENST00000367725.4
|
C1orf105
|
chromosome 1 open reading frame 105 |
chr1_+_167721954 | 0.53 |
ENST00000359523.7
ENST00000392121.7 ENST00000474859.5 |
MPZL1
|
myelin protein zero like 1 |
chr16_+_30023198 | 0.53 |
ENST00000681219.1
ENST00000300575.6 |
C16orf92
|
chromosome 16 open reading frame 92 |
chr7_-_105679089 | 0.53 |
ENST00000477775.5
|
ATXN7L1
|
ataxin 7 like 1 |
chr12_-_49904217 | 0.53 |
ENST00000550635.6
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr2_+_201129318 | 0.53 |
ENST00000417748.1
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
chr2_+_202073282 | 0.52 |
ENST00000459709.5
|
KIAA2012
|
KIAA2012 |
chr22_+_21642287 | 0.52 |
ENST00000248958.5
|
SDF2L1
|
stromal cell derived factor 2 like 1 |
chr2_+_202073249 | 0.52 |
ENST00000498697.3
|
KIAA2012
|
KIAA2012 |
chr11_+_55885920 | 0.51 |
ENST00000244891.3
|
TRIM51
|
tripartite motif-containing 51 |
chr4_+_88378842 | 0.51 |
ENST00000264346.12
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr17_+_19378476 | 0.51 |
ENST00000395604.8
ENST00000482850.1 |
MAPK7
|
mitogen-activated protein kinase 7 |
chr19_-_46746421 | 0.51 |
ENST00000263280.11
|
STRN4
|
striatin 4 |
chr19_-_46788586 | 0.51 |
ENST00000542575.6
|
SLC1A5
|
solute carrier family 1 member 5 |
chr17_+_27631148 | 0.51 |
ENST00000313648.10
ENST00000395473.7 ENST00000577392.5 ENST00000584661.5 |
LGALS9
|
galectin 9 |
chr14_+_21990357 | 0.50 |
ENST00000390444.1
|
TRAV16
|
T cell receptor alpha variable 16 |
chr2_+_238426920 | 0.50 |
ENST00000264607.9
|
ASB1
|
ankyrin repeat and SOCS box containing 1 |
chr19_+_49361783 | 0.50 |
ENST00000594268.1
|
DKKL1
|
dickkopf like acrosomal protein 1 |
chr6_+_31586124 | 0.50 |
ENST00000418507.6
ENST00000376096.5 ENST00000376099.5 ENST00000376110.7 |
LST1
|
leukocyte specific transcript 1 |
chr2_-_207167220 | 0.49 |
ENST00000421199.5
ENST00000457962.5 |
KLF7
|
Kruppel like factor 7 |
chr2_+_135741717 | 0.49 |
ENST00000415164.5
|
UBXN4
|
UBX domain protein 4 |
chr4_+_88378733 | 0.49 |
ENST00000273960.7
ENST00000380265.9 |
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr3_-_37174578 | 0.48 |
ENST00000336686.9
|
LRRFIP2
|
LRR binding FLII interacting protein 2 |
chr11_+_61950370 | 0.48 |
ENST00000449131.6
|
BEST1
|
bestrophin 1 |
chr2_+_201129483 | 0.48 |
ENST00000440180.5
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
chr4_+_8229170 | 0.48 |
ENST00000511002.6
|
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr11_-_2929412 | 0.48 |
ENST00000314222.5
|
PHLDA2
|
pleckstrin homology like domain family A member 2 |
chr15_-_100341899 | 0.47 |
ENST00000568565.2
ENST00000268070.9 |
ADAMTS17
|
ADAM metallopeptidase with thrombospondin type 1 motif 17 |
chr3_-_186362223 | 0.47 |
ENST00000265022.8
|
DGKG
|
diacylglycerol kinase gamma |
chr17_+_80991824 | 0.47 |
ENST00000325167.9
|
CHMP6
|
charged multivesicular body protein 6 |
chr3_-_71130963 | 0.47 |
ENST00000649695.2
|
FOXP1
|
forkhead box P1 |
chr8_+_53851786 | 0.47 |
ENST00000297313.8
ENST00000344277.10 |
RGS20
|
regulator of G protein signaling 20 |
chr7_+_120988683 | 0.47 |
ENST00000340646.9
ENST00000310396.10 |
CPED1
|
cadherin like and PC-esterase domain containing 1 |
chr3_-_71130892 | 0.46 |
ENST00000491238.7
ENST00000674446.1 |
FOXP1
|
forkhead box P1 |
chr15_-_55319107 | 0.46 |
ENST00000565225.1
ENST00000436697.3 ENST00000567948.1 ENST00000563262.5 |
PIGBOS1
RAB27A
|
PIGB opposite strand 1 RAB27A, member RAS oncogene family |
chr9_-_127778659 | 0.46 |
ENST00000314830.13
|
SH2D3C
|
SH2 domain containing 3C |
chr3_-_71130557 | 0.46 |
ENST00000497355.7
|
FOXP1
|
forkhead box P1 |
chr12_+_112906949 | 0.45 |
ENST00000679971.1
ENST00000675868.2 ENST00000550883.2 ENST00000553152.2 ENST00000202917.10 ENST00000679467.1 ENST00000680659.1 ENST00000540589.3 ENST00000552526.2 ENST00000681228.1 ENST00000680934.1 ENST00000681700.1 ENST00000679987.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1 |
chr12_+_128853462 | 0.45 |
ENST00000281703.11
ENST00000442111.6 |
GLT1D1
|
glycosyltransferase 1 domain containing 1 |
chr18_+_58149314 | 0.45 |
ENST00000435432.6
ENST00000357895.9 ENST00000586263.5 |
NEDD4L
|
NEDD4 like E3 ubiquitin protein ligase |
chr7_-_116030735 | 0.45 |
ENST00000393485.5
|
TFEC
|
transcription factor EC |
chr15_+_83447411 | 0.44 |
ENST00000324537.5
|
SH3GL3
|
SH3 domain containing GRB2 like 3, endophilin A3 |
chr1_-_183653307 | 0.44 |
ENST00000308641.6
|
APOBEC4
|
apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4 |
chr15_-_50114491 | 0.44 |
ENST00000559829.5
|
ATP8B4
|
ATPase phospholipid transporting 8B4 (putative) |
chr6_+_79631322 | 0.44 |
ENST00000369838.6
|
SH3BGRL2
|
SH3 domain binding glutamate rich protein like 2 |
chr11_+_61950343 | 0.44 |
ENST00000378043.9
|
BEST1
|
bestrophin 1 |
chr4_+_70226116 | 0.44 |
ENST00000317987.6
|
FDCSP
|
follicular dendritic cell secreted protein |
chr19_-_47471847 | 0.43 |
ENST00000594353.1
ENST00000542837.2 |
SLC8A2
|
solute carrier family 8 member A2 |
chr17_+_34319427 | 0.43 |
ENST00000394620.2
|
CCL8
|
C-C motif chemokine ligand 8 |
chr1_-_120051714 | 0.43 |
ENST00000579475.7
|
NOTCH2
|
notch receptor 2 |
chr1_+_209686173 | 0.43 |
ENST00000615289.4
ENST00000367028.6 ENST00000261465.5 |
HSD11B1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr6_+_26365159 | 0.42 |
ENST00000532865.5
ENST00000396934.7 ENST00000508906.6 ENST00000530653.5 ENST00000527417.5 |
BTN3A2
|
butyrophilin subfamily 3 member A2 |
chr12_+_57434778 | 0.42 |
ENST00000309668.3
|
INHBC
|
inhibin subunit beta C |
chr5_+_141373878 | 0.42 |
ENST00000517434.3
ENST00000610583.1 |
PCDHGA6
|
protocadherin gamma subfamily A, 6 |
chr16_+_56932134 | 0.42 |
ENST00000439977.7
ENST00000300302.9 ENST00000344114.8 ENST00000379792.6 |
HERPUD1
|
homocysteine inducible ER protein with ubiquitin like domain 1 |
chr6_+_31586269 | 0.42 |
ENST00000438075.7
|
LST1
|
leukocyte specific transcript 1 |
chr6_-_114343012 | 0.42 |
ENST00000312719.10
|
HS3ST5
|
heparan sulfate-glucosamine 3-sulfotransferase 5 |
chr11_+_71998892 | 0.42 |
ENST00000393705.8
ENST00000393703.9 ENST00000337131.9 ENST00000620017.4 ENST00000531053.5 ENST00000404792.5 |
IL18BP
|
interleukin 18 binding protein |
chr5_+_68292562 | 0.41 |
ENST00000523872.1
|
PIK3R1
|
phosphoinositide-3-kinase regulatory subunit 1 |
chr18_+_13611910 | 0.41 |
ENST00000590308.1
|
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4 |
chr12_+_123973197 | 0.41 |
ENST00000392404.7
ENST00000337815.9 ENST00000538932.6 ENST00000618862.2 ENST00000389727.8 |
ZNF664
ENSG00000274874.2
RFLNA
|
zinc finger protein 664 novel protein refilin A |
chr19_+_10655023 | 0.41 |
ENST00000590009.5
|
ILF3
|
interleukin enhancer binding factor 3 |
chr7_-_75772172 | 0.41 |
ENST00000005180.9
|
CCL26
|
C-C motif chemokine ligand 26 |
chr6_+_36954729 | 0.40 |
ENST00000373674.4
|
PI16
|
peptidase inhibitor 16 |
chr22_-_43015133 | 0.40 |
ENST00000453643.5
ENST00000263246.8 |
PACSIN2
|
protein kinase C and casein kinase substrate in neurons 2 |
chr11_+_1099730 | 0.40 |
ENST00000674892.1
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming |
chr2_-_216013582 | 0.40 |
ENST00000620139.4
|
MREG
|
melanoregulin |
chr11_-_117828698 | 0.40 |
ENST00000528014.5
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
chr10_+_84424919 | 0.40 |
ENST00000543283.2
ENST00000494586.5 |
CCSER2
|
coiled-coil serine rich protein 2 |
chr3_+_119468952 | 0.40 |
ENST00000476573.5
ENST00000295588.9 |
POGLUT1
|
protein O-glucosyltransferase 1 |
chr19_-_40218339 | 0.39 |
ENST00000311308.6
|
TTC9B
|
tetratricopeptide repeat domain 9B |
chr15_+_73684204 | 0.39 |
ENST00000537340.6
ENST00000318424.9 |
CD276
|
CD276 molecule |
chr10_-_73625951 | 0.39 |
ENST00000433394.1
ENST00000422491.7 |
USP54
|
ubiquitin specific peptidase 54 |
chr3_+_41199462 | 0.39 |
ENST00000647264.1
ENST00000645900.1 ENST00000646174.1 ENST00000643992.1 ENST00000647390.1 ENST00000642886.1 |
CTNNB1
|
catenin beta 1 |
chr22_-_50085414 | 0.39 |
ENST00000311597.10
|
MLC1
|
modulator of VRAC current 1 |
chr9_+_99105098 | 0.39 |
ENST00000374990.6
ENST00000374994.9 ENST00000552516.5 |
TGFBR1
|
transforming growth factor beta receptor 1 |
chr16_-_87936529 | 0.39 |
ENST00000649794.3
ENST00000649158.1 ENST00000648177.1 |
CA5A
|
carbonic anhydrase 5A |
chr12_+_48978313 | 0.39 |
ENST00000293549.4
|
WNT1
|
Wnt family member 1 |
chr22_+_23696400 | 0.39 |
ENST00000452208.1
|
RGL4
|
ral guanine nucleotide dissociation stimulator like 4 |
chr3_+_39051990 | 0.38 |
ENST00000302313.10
|
WDR48
|
WD repeat domain 48 |
chr18_-_28177934 | 0.38 |
ENST00000676445.1
|
CDH2
|
cadherin 2 |
chr2_+_168802610 | 0.38 |
ENST00000397206.6
ENST00000317647.12 ENST00000397209.6 |
NOSTRIN
|
nitric oxide synthase trafficking |
chr17_+_6756035 | 0.38 |
ENST00000361842.8
ENST00000574907.5 |
XAF1
|
XIAP associated factor 1 |
chr3_+_155083523 | 0.38 |
ENST00000680057.1
|
MME
|
membrane metalloendopeptidase |
chr8_-_23069012 | 0.38 |
ENST00000347739.3
ENST00000276431.9 |
TNFRSF10B
|
TNF receptor superfamily member 10b |
chr1_+_149899618 | 0.38 |
ENST00000369150.1
|
BOLA1
|
bolA family member 1 |
chr6_+_150721073 | 0.38 |
ENST00000358517.6
|
PLEKHG1
|
pleckstrin homology and RhoGEF domain containing G1 |
chr19_+_49363923 | 0.37 |
ENST00000597546.1
|
DKKL1
|
dickkopf like acrosomal protein 1 |
chr2_+_201129826 | 0.37 |
ENST00000457277.5
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
chr5_+_172959511 | 0.37 |
ENST00000519522.1
|
RPL26L1
|
ribosomal protein L26 like 1 |
chr17_+_48107743 | 0.37 |
ENST00000359238.7
ENST00000582104.5 ENST00000584335.5 |
SNX11
|
sorting nexin 11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.1 | 5.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.6 | 1.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 1.6 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
0.5 | 1.4 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.4 | 0.8 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.3 | 1.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.3 | 1.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.3 | 2.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.3 | 0.9 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.3 | 3.8 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 4.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.7 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
0.2 | 2.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 0.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 1.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 2.3 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 0.8 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.2 | 0.8 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) |
0.2 | 0.6 | GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
0.2 | 0.6 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.2 | 1.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 1.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.7 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.2 | 1.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.4 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.2 | 0.5 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.2 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 1.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.6 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.2 | 0.6 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 0.5 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.2 | 0.6 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.5 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.2 | 0.9 | GO:1904501 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.1 | 0.4 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.7 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 0.3 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.1 | 0.4 | GO:1903004 | flavin adenine dinucleotide metabolic process(GO:0072387) regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
0.1 | 1.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.4 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
0.1 | 0.7 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.5 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.4 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.6 | GO:0015692 | lead ion transport(GO:0015692) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 1.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 0.5 | GO:1904640 | response to methionine(GO:1904640) |
0.1 | 0.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.3 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.1 | 0.6 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 0.2 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
0.1 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.3 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 0.3 | GO:0071626 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
0.1 | 0.8 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.3 | GO:0090133 | mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
0.1 | 0.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 1.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.1 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.5 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 1.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.2 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
0.1 | 1.4 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
0.1 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.5 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.2 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.1 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 0.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.2 | GO:0048058 | compound eye corneal lens development(GO:0048058) |
0.1 | 0.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.3 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.1 | 0.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.3 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.2 | GO:0061573 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
0.1 | 0.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.2 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.1 | 1.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 1.8 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.1 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 1.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 1.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 0.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.4 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.6 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.4 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.1 | 0.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.6 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.2 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.1 | 1.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 0.2 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.1 | 0.2 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 1.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.7 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.1 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.0 | 0.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 1.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 1.8 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 1.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.0 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.0 | 1.8 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 0.2 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.0 | 0.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.1 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
0.0 | 0.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.0 | 0.1 | GO:0097272 | ammonia homeostasis(GO:0097272) urea homeostasis(GO:0097274) |
0.0 | 0.3 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.6 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.4 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 1.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.8 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.9 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.2 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.0 | 0.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.2 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.0 | 0.8 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.0 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.2 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
0.0 | 0.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.1 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.0 | 0.3 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.0 | 0.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.0 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:0003290 | septum secundum development(GO:0003285) atrial septum secundum morphogenesis(GO:0003290) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.1 | GO:0001812 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.0 | 0.4 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.0 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.1 | GO:0009631 | cold acclimation(GO:0009631) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.3 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.2 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.0 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 0.1 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
0.0 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.1 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.0 | 0.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.0 | 0.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.0 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.0 | 0.9 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) negative regulation of gastrulation(GO:2000542) |
0.0 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.0 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.0 | 0.3 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.0 | 0.4 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.3 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.0 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.5 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:0032595 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
0.0 | 0.1 | GO:0031438 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.5 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.4 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.1 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.0 | 0.1 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.0 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.0 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 3.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.0 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.0 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.0 | 0.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.0 | 0.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 1.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.1 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
0.0 | 0.2 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.1 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.0 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.2 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.0 | 0.2 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 1.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) regulation of rRNA processing(GO:2000232) |
0.0 | 0.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.3 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.1 | GO:1904753 | positive regulation of heart rate by epinephrine(GO:0003065) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.0 | 0.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.2 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.0 | GO:1903517 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) regulation of single strand break repair(GO:1903516) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.0 | 0.1 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.0 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 1.1 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.0 | 0.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.0 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.0 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.1 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.4 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.0 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 3.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 1.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 0.8 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.2 | 1.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.5 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 0.5 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.6 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.9 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.9 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.3 | GO:0070701 | mucus layer(GO:0070701) |
0.1 | 0.4 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 2.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 1.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.4 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.0 | 0.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.0 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.0 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0044301 | climbing fiber(GO:0044301) |
0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.0 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0071752 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.0 | 1.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.5 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 2.4 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.7 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 1.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 4.3 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 1.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.4 | 1.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 1.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 1.0 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.3 | 1.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 0.7 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
0.2 | 1.1 | GO:0004803 | transposase activity(GO:0004803) |
0.2 | 0.7 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.2 | 0.6 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
0.2 | 0.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 1.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.8 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.9 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.6 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 2.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 6.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.1 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.5 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.4 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 3.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 1.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.5 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 2.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.5 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 2.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.2 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 1.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 0.3 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.0 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 1.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.2 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
0.0 | 0.1 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.0 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.0 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.0 | 0.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.0 | 0.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.3 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.0 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.9 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.0 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 1.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 5.6 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.0 | 0.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 0.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.0 | 0.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.0 | 0.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.1 | GO:0043273 | CTPase activity(GO:0043273) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.5 | GO:0016502 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.3 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 3.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 2.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.1 | GO:0050610 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 0.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 1.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 1.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 2.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 4.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 5.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 3.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 3.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 1.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 5.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 3.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 6.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 3.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 2.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 5.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 1.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 1.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 2.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 2.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |